Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)

NCT00228423 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

113

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: Clopidogrel 75 mg daily
DRUG: water pill daily

Sponsor

Ottawa Heart Institute Research Corporation

Collaborators

[object Object]
[object Object]